Reaction

Epidural Lipomatosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 344 reports · 33 co-occurring drugs

As of the last recalculation, Epidural Lipomatosis appears in 344 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 379.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dimenhydrinate56379.6381.6
Bisacodyl Suppositories52286.3287.4
Biscodyl52283.7284.8
Phenobarbital55273.2274.2
Bisacodyl53269.2270.2
Methocarbamol Tablets42172.7173.2
Clobazam55162.1162.4
Methocarbamol43130.8131.1
Instalax Polyethylene Glycol 335023120.1120.3
Polyethylene Glycol 40023117.5117.7
Canakinumab19112.4112.6
Anakinra26102.5102.7
Aripiprazole Oral5595.695.7
Aripiprazole Orally Disintegrating5595.695.7
Tofacitinib Citrate1992.892.9
Thiotepa1385.685.7
Methadone5184.584.6
Clonidine5475.575.5
Melatonin5572.672.6
Theophylline1265.465.5
Theophylline Anhydrous1260.660.7
Vigabatrin1460.560.6
Fluticasone Propionate Nasal2758.458.5
Diphenhydramine4954.554.6
Fluticasone Furoate1051.451.5
Hydroxychloroquine5350.650.6
Montelukast5547.047.0
Baclofen5646.846.8
Fluoxetine4344.544.5
Leuprolide Acetate4742.342.3
Vemurafenib736.036.0
Methadone Hydrochloride528.428.4
Ranitidine Hydrochloride1213.813.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.